Anal cancer rates are rising among people living with HIV. The goal of the ANCHOR study is to find the best way to prevent anal cancer among people living with HIV.
During a screening visit, you will be screened for pre-cancerous anal lesions, i.e., HSIL. If HSIL is found, you will be enrolled and randomized to either have the it treated or followed very carefully without treatment every six months.
Both groups will be followed for a minimum of five years. You will be compensated $100 for the screening visit and if you are enrolled, for every visit at which you have an anoscopy.
Ensuring A Quality Experience Once Enrolled
All study participants are instructed to call the clinic in the case of an adverse event, and are given the clinic's contact information for reporting those events. If a participant wishes to report an adverse event, provide feedback to the national team or the CAB, guidelines for doing so are also available in the "Let's Talk" section of the website.
Additional Resources for your Patients
Additional resources such as infocards about HPV and HRA are available from the ANCHOR study upon request. We have also provided online resources via links in the "For Participants" section of this website and in the sidebar of this page.